Search Results

OBiO Technology Corp., Ltd. will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th.

Mammoth Biosciences today announced that Lucas Harrington, Ph.D., Mammoth’s co-founder and Chief Scientific Officer, will present new preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, May 7 - 11, 2024.

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it will present novel research and exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting to be held in Baltimore, MD from May 7-11.

Bio-Techne Corporation announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy, taking place May 7-11, 2024, in Baltimore, Maryland.

Sania Therapeutics today announces that it will be presenting three posters at the American Society of Gene & Cell Therapy 2024 Annual Meeting, taking place from 7-11 May 2024 in Baltimore, MD.

Forge Biologics Announces Nine Presentations at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting.

Ginkgo Bioworks announced its participation in the 27th American Society of Gene & Cell Therapy Annual Meeting, May 7-11, in Baltimore, MD. Ginkgo will present three posters in cell therapy and give one oral presentation in mRNA therapeutics.

Rejuvenate Bio today announced an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting, taking place May 7 – 11, 2024, in Baltimore, MD and virtually.